A study of 42 state Medicaid programs found that 58% of prescriptions for antipsychotics were not for schizophrenia or bipolar disorder. Off-label prescribing was most prevalent among individuals under 21 years of age (76%) or over 65 (65%), as opposed to 49% for those between 21 and 64 years. The authors note that the medications are expensive and have limited evidence of effectiveness. Results are published in this month’s American Journal of Managed Care.
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.